Fabrega A J, DeChristopher J, Sosler S D, Rivas P A, Vasquez E M, Pollak R
Department of Surgery/Division of Transplantation, University of Illinois, Chicago Medical Center, USA.
Clin Transplant. 1996 Apr;10(2):166-9.
We report three instances of antibody-mediated hemolytic anemia following ABO-mismatched, but compatible, renal (n = 2) and simultaneous pancreas-kidney (n = 1) transplantation. The two renal allograft recipients had received a 6-antigen matched transplant; one received polyclonal antilymphocyte globulin to treat an early rejection episode. The simultaneous pancreas-kidney transplant received polyclonal antilymphocyte globulin (ALG) as part of a quadruple therapy induction regimen. All three patients developed severe, but self-limited, antibody-mediated hemolytic anemia within two weeks of their transplants. Serologic testing demonstrated the hemolysis to be antibody mediated; furthermore, testing of the ALG lots demonstrated high titers of anti-red blood cell antibodies. The possible contribution of ALG and HLA matching to the hemolysis seen in these patients after ABO mismatched organ transplantation is discussed.
我们报告了3例在ABO血型不匹配但相容的肾移植(n = 2)和胰肾联合移植(n = 1)后发生抗体介导的溶血性贫血的病例。2例肾移植受者接受了6抗原匹配的移植;其中1例接受了多克隆抗淋巴细胞球蛋白治疗早期排斥反应。胰肾联合移植受者接受了多克隆抗淋巴细胞球蛋白(ALG)作为四联诱导治疗方案的一部分。所有3例患者在移植后两周内均发生了严重但自限性的抗体介导的溶血性贫血。血清学检测表明溶血是由抗体介导的;此外,对ALG批次的检测显示抗红细胞抗体的高滴度。讨论了ALG和HLA匹配对这些患者在ABO血型不匹配器官移植后出现溶血的可能作用。